Company Filing History:
Years Active: 2024
Title: Samir Yahiaoui: Innovator in Pharmaceutical Research
Introduction
Samir Yahiaoui is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target bacterial infections.
Latest Patents
Yahiaoui holds a patent for "PqsR inverse agonists." This invention relates to a compound that acts as an inhibitor of PqsR, the only known receptor for the Quinolone Signal (PQS). The patent includes a pharmaceutical composition containing one or more of the compounds of the invention, as well as a combination preparation that includes at least one compound of the invention and at least one further active pharmaceutical ingredient. The uses of these compounds include their application as a medicament, particularly in the treatment or prophylaxis of bacterial infections.
Career Highlights
Samir Yahiaoui is affiliated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he conducts research and development in the field of infectious diseases. His work focuses on innovative solutions to combat bacterial infections, showcasing his commitment to advancing medical science.
Collaborations
Yahiaoui collaborates with esteemed colleagues, including Ahmed S A Ahmed and Martin Empting. These partnerships enhance the research efforts at Helmholtz-Zentrum für Infektionsforschung GmbH and contribute to the development of effective pharmaceutical solutions.
Conclusion
Samir Yahiaoui's contributions to pharmaceutical research, particularly through his patent on PqsR inverse agonists, highlight his role as an innovator in the field. His work continues to pave the way for advancements in the treatment of bacterial infections.